Cargando…
Flurofamide Prevention and Treatment of Ureaplasma-Induced Hyperammonemia
Hyperammonemia (HA) syndrome caused by respiratory infection with ammonia (NH(3))-producing Ureaplasma species occurs in 4% of lung transplant recipients (LTRs) and is associated with high mortality. Although Ureaplasma-targeted antibiotic intervention is effective, the threat of antibiotic resistan...
Autores principales: | Fleming, Derek, Patel, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602998/ https://www.ncbi.nlm.nih.gov/pubmed/35993783 http://dx.doi.org/10.1128/spectrum.01927-22 |
Ejemplares similares
-
Contribution of Uremia to Ureaplasma-Induced Hyperammonemia
por: Fleming, Derek, et al.
Publicado: (2022) -
Inhibition of the growth of Ureaplasma urealyticum by a new urease inhibitor, flurofamide.
por: Kenny, G. E.
Publicado: (1983) -
Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model
por: Wang, Xiaohui, et al.
Publicado: (2016) -
Hyperammonemia by Ureaplasma urealyticum Pneumonia after Lung Transplantation
por: Paparoupa, Maria, et al.
Publicado: (2020) -
Hyperammonemia in a septic patient with Ureaplasma parvum arthritis: a case report
por: Pan, Xiaohong, et al.
Publicado: (2022)